NCT04845919View on ClinicalTrials.gov

Sonodynamic Therapy with ExAblate System in Glioblastoma Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

February 22, 2023

Primary Completion Date

October 30, 2024

Study Completion Date

October 30, 2024

Conditions
Glioblastoma Multiforme
Interventions
DRUG

5-Aminolevulinic Acid

"SDT treatment with 5-ALA using the ExAblate Model 4000 Type-2 Neuro-System."

Trial Locations (1)

20133

Foundation IRCCS Carlo Besta Neurological Institute, Milan

All Listed Sponsors
lead

Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

OTHER